文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

急诊科收治脓毒症患者第二剂抗生素延迟:发生率、危险因素与结局

Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论急诊收治的脓毒症患者中,第二剂抗生素重大延迟常见(33%),尤其见于推荐间隔短、急诊滞留及初始3小时集束化治疗达标的患者,并与住院死亡率及机械通气增加相关。

该回顾性连续样本脓毒症队列研究纳入了10个月内从急诊收治的828例脓毒症或脓毒性休克患者,旨在确定第二剂抗生素延迟的频率与幅度、危险因素,并探索延迟与患者结局的关联。重大延迟定义为第一至第二剂时间≥推荐间隔的25%。结果显示272例(33%)发生重大延迟,延迟频率随推荐间隔缩短而剂量依赖性增加:24小时间隔4%(中位时间18.52小时)、12小时间隔26%(中位10.58小时)、8小时间隔47%(中位9.60小时)、6小时间隔72%(中位9.55小时)。多变量回归中,间隔长度显著预测重大延迟(12小时OR 6.98,95%CI 2.33-20.89;8小时OR 23.70,95%CI 8.13-69.11;6小时OR 71.95,95%CI 25.13-206.0),其他独立危险因素包括急诊科住院滞留(OR 2.67,95%CI 1.74-4.09)、初始3小时脓毒症集束化治疗达标(OR 1.57,95%CI 1.07-2.30)及年龄较大(每10年OR 1.16,95%CI 1.01-1.34)。探索性多变量分析中,重大延迟与住院死亡率增加(OR 1.61,95%CI 1.01-2.57)及机械通气(OR 2.44,95%CI 1.27-4.69)相关。

要点

  • 828例急诊收治脓毒症患者中272例(33%)发生第二剂抗生素重大延迟(第一至第二剂时间≥推荐间隔25%)。
  • 延迟频率随推荐间隔缩短而升高:24小时间隔4%(中位18.52小时)、12小时26%(中位10.58小时)、8小时47%(中位9.60小时)、6小时72%(中位9.55小时)。
  • 多变量回归中,推荐间隔6小时预测重大延迟的OR为71.95(95%CI 25.13-206.0),12小时OR 6.98(95%CI 2.33-20.89),8小时OR 23.70(95%CI 8.13-69.11)。
  • 急诊科住院滞留(OR 2.67,95%CI 1.74-4.09)、初始3小时脓毒症集束化治疗达标(OR 1.57,95%CI 1.07-2.30)及年龄较大(每10年OR 1.16,95%CI 1.01-1.34)为独立危险因素。
  • 探索性分析中,重大延迟与住院死亡率增加(OR 1.61,95%CI 1.01-2.57)及机械通气(OR 2.44,95%CI 1.27-4.69)相关。

适用人群与场景

  • 所有从急诊科收治的脓毒症或脓毒性休克患者(脓毒症定义:感染、≥2项全身炎症反应综合征标准、低灌注/器官功能障碍),由前瞻性质量改进项目识别。
  • 排除标准:年龄<18岁、未在急诊科接受初始抗生素、在抗生素再次给药前死亡、患者拒绝抗生素。

诊断标准与关键阈值

  • 脓毒症或脓毒性休克定义:感染、≥2项全身炎症反应综合征标准、低灌注/器官功能障碍。
  • 重大延迟定义:第一至第二剂抗生素时间≥推荐间隔的25%。

研究设计与关键结果

  • 研究设计:回顾性、连续样本脓毒症队列,为期10个月,单中心、三级学术医疗中心。
  • 样本量:828例脓毒症病例。
  • 主要终点:272例(33%)发生重大延迟(第一至第二剂时间≥推荐间隔25%)。
  • 延迟频率随推荐间隔缩短而剂量依赖性增加:24小时间隔11例(4%)延迟(中位时间18.52小时);12小时间隔31例(26%)延迟(中位10.58小时);8小时间隔117例(47%)延迟(中位9.60小时);6小时间隔113例(72%)延迟(中位9.55小时)。
  • 多变量回归中,间隔长度显著预测重大延迟:12小时OR 6.98(95%CI 2.33-20.89);8小时OR 23.70(95%CI 8.13-69.11);6小时OR 71.95(95%CI 25.13-206.0)。
  • 其他独立危险因素:急诊科住院滞留OR 2.67(95%CI 1.74-4.09);初始3小时脓毒症集束化治疗达标OR 1.57(95%CI 1.07-2.30);年龄较大每10年OR 1.16(95%CI 1.01-1.34)。
  • 探索性多变量分析:重大延迟与住院死亡率增加相关(OR 1.61,95%CI 1.01-2.57),与机械通气相关(OR 2.44,95%CI 1.27-4.69)。

证据类型、等级与局限

  • 证据类型:回顾性、连续样本队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重大第二剂延迟常见,尤其见于接受较短半衰期药物治疗及在急诊科滞留的患者; paradoxically 更常见于接受达标初始治疗的患者。
  • 作者观察到重大第二剂延迟与死亡率增加、住院时间延长及机械通气需求相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: 1) Determine frequency and magnitude of delays in second antibiotic administration among patients admitted with sepsis; 2) Identify risk factors for these delays; and 3) Exploratory: determine association between delays and patient-centered outcomes (mortality and mechanical ventilation after second dose).

DESIGN: Retrospective, consecutive sample sepsis cohort over 10 months.

SETTING: Single, tertiary, academic medical center.

PATIENTS: All patients admitted from the emergency department with sepsis or septic shock (defined: infection, ≥ 2 systemic inflammatory response syndrome criteria, hypoperfusion/organ dysfunction) identified by a prospective quality initiative.

EXCLUSIONS: less than 18 years old, not receiving initial antibiotics in the emergency department, death before antibiotic redosing, and patient refusing antibiotics.

INTERVENTIONS: We determined first-to-second antibiotic time and delay frequency. We considered delay major for first-to-second dose time greater than or equal to 25% of the recommended interval. Factors of interest were demographics, recommended interval length, comorbidities, clinical presentation, location at second dose, initial resuscitative care, and antimicrobial activity mechanism.

MEASUREMENTS AND MAIN RESULTS: Of 828 sepsis cases, 272 (33%) had delay greater than or equal to 25%. Delay frequency increased dose dependently with shorter recommended interval: 11 (4%) delays for 24-hour intervals (median time, 18.52 hr); 31 (26%) for 12-hour intervals (median, 10.58 hr); 117 (47%) for 8-hour intervals (median, 9.60 hr); and 113 (72%) for 6-hour intervals (median, 9.55 hr). In multivariable regression, interval length significantly predicted major delay (12 hr: odds ratio, 6.98; CI, 2.33-20.89; 8 hr: odds ratio, 23.70; CI, 8.13-69.11; 6 hr: odds ratio, 71.95; CI, 25.13-206.0). Additional independent risk factors were inpatient boarding in the emergency department (odds ratio, 2.67; CI, 1.74-4.09), initial 3-hour sepsis bundle compliance (odds ratio, 1.57; CI, 1.07-2.30), and older age (odds ratio, 1.16 per 10 yr, CI, 1.01-1.34). In the exploratory multivariable analysis, major delay was associated with increased hospital mortality (odds ratio, 1.61; CI, 1.01-2.57) and mechanical ventilation (odds ratio, 2.44; CI, 1.27-4.69).

CONCLUSIONS: Major second dose delays were common, especially for patients given shorter half-life pharmacotherapies and who boarded in the emergency department. They were paradoxically more frequent for patients receiving compliant initial care. We observed association between major second dose delay and increased mortality, length of stay, and mechanical ventilation requirement.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Leisman D, Huang V, Zhou Q, et al. Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes. Crit Care Med. 2017. PMID: 28328652. doi:10.1097/CCM.0000000000002377

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。